Journal for ImmunoTherapy of Cancer (Nov 2020)

399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial

  • Dean Harris,
  • Daniel Brungs,
  • Rahul Ladwah,
  • Andrew Mant,
  • Margaret McGrath,
  • Andrea Tazbirkova,
  • Andrey Akopov,
  • Natalia Fadeeva,
  • Boris Kasparov,
  • Nadezhda Kovalenko,
  • Vadim Kozlov,
  • Fedor Moiseenko,
  • Vasiliy Oschepkov,
  • Piotr Koralewski,
  • Dariusz Kowalski,
  • Iwona Lugowska,
  • Chaiyut Charoentumn,
  • Arunee Dechaphunkul,
  • Virote Sriuranpong,
  • James Oliviero,
  • Philip Clingan

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0399
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.